Finance Minister Thangam Thennarasu on Friday (March 14, 2025) said to boost tourist arrivals in south Tamil Nadu and promote ...

The initiative aims to boost tourism in South Tamil Nadu and contribute to the economic development of the region ...

up by 5% in c Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming ...

Oakland Dental Care is excited to announce that Dr. James P. Sara has officially joined the practice. Bringing a wealth of expertise and a passion for exceptional dental care, Dr. Sara is a valuable ...

BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 ...

The global difficult-to-express protein market is on track for remarkable expansion, with a projected compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, according to a recent report by ...

In today’s evolving pharmaceutical environment, the fill‐finish segment stands out as a critical linchpin connecting drug ...

LXP is a $2.7 billion REIT in the industrial sector. The company's focus is on buying, developing and operating high-quality, ...

CT-P13, intravenous infliximab, developed and manufactured by Celltrion, is the first monoclonal antibody biosimilar therapy and has been the most established biosimilar treatment in the Canadian ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...